AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

leronlimab

3 people · 4 posts · 2 abstracts

Evidence

1033

Leronlimab induces PD-L1 expression and is associated with long-term survival with an ICI in PD-L1 low metastatic TNBC

Richard G. Pestell, Ritika Harish, Zhiping Li, Danni Li, Xuanmao Jiao, Hallgeir Rui, Massimo Cristofanilli, Daniel L. Adams, Neil E. Buss, Jonah B. Sacha, Jacob P. Lalezari

Read the abstract →

6466

Preliminary results of a phase 2 study of leronlimab in combination with TAS-102 and bevacizumab in previously treated metastatic colorectal cancer

Pashtoon M. Kasi, Ari Baron, Arvind Chaudhry, Laura Tenner, Daniel L. Adams, Alexis B. Duffy, Hallgeir Rui, Patrick Vittner, Joseph Meidling, Jacob P. Lalezari

Read the abstract →

Floor

Oct 11Sun

Sunday · 1 items

19:41
reddit.comScore1010
The Convergence: What All of This Has Been Moving Toward
Same topic leronlimab · 3 peopleNo engagement yet

Apr 22Wed

Wednesday · 1 items

05:04
x.com@Score6060
#AACR26 Excited & honored to unveil initial results from the phase-2 CLOVER ☘️ trial.
Same topic leronlimab · 3 people VEGF #CTDNA #COLORECTALCANCERHeat 8251 likes7 replies24 reposts

Apr 21Tue

Tuesday · 2 items

22:36
Pashtoon Kasi MD, MS@pashtoonkasiScore6060
#AACR26 2-5 pm today
Same topic leronlimab · 3 people VEGF #COLORECTALCANCERHeat 3526 likes0 replies9 reposts
09:52
Pashtoon Kasi MD, MS@pashtoonkasiScore6060
#AACR26 Come to our session tomorrow.
Same topic leronlimab · 3 people VEGF #COLORECTALCANCERHeat 3626 likes2 replies8 reposts

The Convergence: What All of This Has Been Moving Toward